Home Crystal structures of complexes of mouse thymidylate synthase crystallized with N4-OH-dCMP alone or in the presence of N5,10-methylenetetrahydrofolate
Article Open Access

Crystal structures of complexes of mouse thymidylate synthase crystallized with N4-OH-dCMP alone or in the presence of N5,10-methylenetetrahydrofolate

  • Anna Dowierciał , Adam Jarmuła , Piotr Wilk , Wojciech Rypniewski , Borys Kierdaszuk and Wojciech Rode EMAIL logo
Published/Copyright: May 3, 2013
Become an author with De Gruyter Brill

Abstract

To solve the inhibition mechanism of thymidylate synthase (TS) by N4-hydroxy-dCMP (N4-OH-dCMP), crystallographic studies were undertaken. Structures of three mouse TS (mTS) complexes with the inhibitor were solved, based on crystals formed by the enzyme protein in the presence of either only N4-OH-dCMP [crystal A, belonging to the space group C 1 2 1, with two monomers in asymmetric unit (ASU), measured to 1.75 Å resolution] or both N4-OH-dCMP and N5,10-methylenetetrahydrofolate (mTHF) (crystals B and C, both belonging to the space group C 2 2 21, each with a single monomer in ASU, measured to resolution of 1.35 Å and 1.17 Å, respectively). Whereas crystal A-based structure revealed the mTS-N4-OH-dCMP binary complex, as expected, crystals B- and C-based structures showed the enzyme to be involved in a ternary complex with N4-OH-dCMP and noncovalently bound dihydrofolate (DHF), instead of expected mTHF, suggesting the inhibition to be a consequence of an abortive enzyme-catalyzed reaction, involving a transfer of the one-carbon group to a hitherto unknown site and oxidation of THF to DHF. Moreover, both C(5) and C(6) inhibitor atoms showed sp3 hybridization, suggesting C(5) reduction, with no apparent indication of C(5) proton release. In accordance with our previous results, in all subunits of these structures the inhibitor molecule was identified as the anti rotamer of imino tautomer, forming, similar to deoxyuridine monophosphate, two hydrogen bonds with a conservative asparagine (mouse Asn220) side chain.

Introduction

Thymidylate synthase (TS; EC 2.1.1.45), a target in chemotherapy, catalyzes the conversion of deoxyuridine monophosphate (dUMP) and N5,10-methylenetetrahydrofolate (mTHF) to deoxythymidine monophosphate (dTMP) and dihydrofolate (DHF) via reductive methylation, in which mTHF serves as both methyl donor and reducing agent [1].

N4-hydroxy-dCMP (N4-OH-dCMP) is a substrate analog, reported to inhibit the enzyme from bacterial, avian and mammalian sources, as well as from certain helminths; inhibition is found to be competitive with respect to dUMP, time- and mTHF-dependent, and accompanied by formation of a ternary complex, N4-hydroxy-dCMP-mTHF-enzyme, with apparently differing interactions between the low-molecular weight components and each of the two enzyme subunits [2–6]. Similar to FdUMP, incubated with the cofactor and the enzyme N4-OH-dCMP formed a ternary complex. However, when N4-OH-[5-3H]dCMP replaced dUMP in the reaction mixture, 3H abstraction from the uracil ring C(5) was not apparent, suggesting the reaction to be inhibited at an earlier stage than with FdUMP. In solution the equilibrium between rotamers (Figure 1) around the C4-N4 bond is significantly shifted towards syn rotamer [relative to pyrimidine N(3)] [7, 8], but surprisingly only the anti isomer appeared to be the active inhibitor form [4].

Figure 1 Amino-imino and syn-anti equilibria for N4-hydroxy derivatives of dCMP.
Figure 1

Amino-imino and syn-anti equilibria for N4-hydroxy derivatives of dCMP.

To learn more about the inhibition mechanism, structural studies of TS complexes with N4-OH-dCMP were undertaken.

Materials and methods

Crystallization and data collection

Mouse TS (mTS) recombinant protein, overexpressed and purified as previously described [9], was dialyzed against 5 mM Tris HCl buffer, pH 7.5, containing 5 mM DTT and then concentrated using Amicon Centricon centrifugal filter. Crystals were grown by the vapor diffusion method in hanging drops at approximately 4°C (crystal A)/7°C (crystals B and C) at the following conditions. For two-molecules complex of mTS with N4-hydroxy-dCMP, a drop of protein solution of 30 mg/mL concentration containing inhibitor of 6 mM was mixed 1:1 with well solution (0.1 M Mes pH 6.5; 0.2 M MgAcetate; 13.5% PEG 8000) and allowed to equilibrate with 0.5 mL of well solution. In the case of crystals B and C, equal volumes of protein solution of 16.3 mg/mL concentration and well solution were mixed and allowed to equilibrate with 0.5 mL of well solution, containing 0.1 M Mes, pH 6.5/crystal B or pH 6.7/crystal C; 0.06 M MgAcetate and 16% (w/v) PEG 8000.

X-ray diffraction data were collected from single flash-frozen crystals (A, B and C) at the Bessy Synchrotron using X-rays of 0.918 Å wavelength.

Data processing: structure determination and refinement

Data were processed with Denzo and Scalepack [10]. The crystal A-based structure was determined by refining the model of mTS complexed with SO42– (PDB ID: 3IHI) relative to the new data. In the case of crystal B, the structure was determined by molecular replacement carried out with the Phaser from CCP4 package [11], using the model of mTS-N4-hydroxy-dCMP as the search model. The crystal C-based structure was determined by refining the model of crystal B-based structure with respect to the new data.

The correctness of these structures was evaluated using Sfcheck and Procheck from the CCP4 suite. Some X-ray data and model refinement parameters are summarized in Table 1.

Table 1

Data collection and refinement statistics for mTS-N4-OH-dCMP (crystal A) and mTS-N4-OH-dCMP-DHF (crystals B and C) structures.

mTS-N4-OH-dCMP (crystal A)mTS-N4-OH-dCMP-DHF (crystal B)mTS-N4-OH-dCMP-DHF (crystal C)
Lattice typeMonoclinicOrthorhombicOrthorhombic
Space groupC 1 2 1C 2 2 21C 2 2 21
Unit cell parametersa=160.02 Åa=71.297 Åa=71.121 Å
b=87.96 Åb=111.931 Åb=112.045 Å
c=68.67 Åc=88.237 Åc=88.297 Å
α=90.00°α=α=γ=90.00°α=α=γ=90.00°
β=96.44°
γ=90.00°
Resolution range, Å20–1.7528.46–1.3521.35–1.17
No. of unique reflections90, 89277, 525117, 370
Redundancy2.27.15.4
< I/σ(Ι) >10.111.99.8
No. of reflections used in refinement86, 32273, 587117, 324
R factor, %20.610.410.7
Rfree factor, %25.513.113.0
RMS bond, Å0.0240.0230.023
RMS angle, °1.9732.0662.013

Results and discussion

Structures of three mTS complexes with the inhibitor were solved, based on crystals formed by the enzyme protein in the presence of either only N4-OH-dCMP [crystal A, belonging to the space group C 1 2 1, with two monomers in asymmetric unit (ASU), measured to 1.75 Å resolution] or both N4-OH-dCMP and mTHF (crystals B and C, both belonging to the space group C 2 2 21, each with a single monomer in ASU, measured to resolution of 1.35 Å and 1.17 Å, respectively). For both subunits of the dimer structure of the mTS-N4-OH-dCMP binary complex (structure A), the electron density map is well defined and continuous for the entire molecules of ligand and throughout the protein chains, except for poorly defined loops Glu 42-Thr 47. The mTS-N4-OH-dCMP structure is very similar to that of an analogous mTS complex with the substrate, dUMP [9] (Figure 2), as indicated by Cα root mean square deviation (RMSD) between subunits A of both structures amounting to 0.33 Å. Both structures show the protein in the active conformation, with the catalytic Cys 189 located in the active site and extended towards the ligands (Figure 3). The distances between the C6 atoms in the pyrimidine rings of N4-OH-dCMP and the sulfur atoms of Cys 189 are 2.87 and 2.94 Å in subunits A and B, respectively, showing the lack of bonding between the enzyme and ligand, as in the mTS-dUMP structure. The molecules of dUMP and N4-OH-dCMP preserve virtually the same positions (Figures 2 and 3), both being anchored in the active site by their phosphate moieties, each forming several H-bonds with the quartet of arginines of both TS subunits (Arg 44 and Arg 209 from one subunit and Arg 169′ and Arg 170’ from the other subunit) and a single serine (Ser 210) (not shown). Comparison of the active sites of both structures (Figure 3) reveals different positions of two conservative water molecules. The lower cyan molecule in Figure 3 is located at a H-bond distance from the uracil O4 atom of dUMP. In the mTS-N4-OH-dCMP structure this water molecule (lower green) appears to be displaced by approximately 2.3 Å, thus being able to participate in a modified H-bonding network between the N4-OH group of N4-OH-dCMP and the conservative Glu 81 side chain. The second conservative water molecule has also been displaced from the higher cyan position in mTS-dUMP to higher green position in mTS-N4-OH-dCMP, presumably to stabilize an alternative conformation of the Ser 223 side chain in the latter structure. Our model of the mTS-N4-OH-dCMP complex shows that the inhibitor molecule preserves the hydrogen bonds [from N(3)-H and N(4) of the cytosine base] to the highly conservative Asn 220, complying with the mechanism of substrate orientation and recognition by TS [12–14].

Figure 2 Superimposition of subunits A in mTS-N4-OH-dCMP (green) and mTS-dUMP (cyan) complexes. Ligands, N4-OH-dCMP and dUMP, are shown as sticks. C- and N-termini of the protein chain are marked.
Figure 2

Superimposition of subunits A in mTS-N4-OH-dCMP (green) and mTS-dUMP (cyan) complexes. Ligands, N4-OH-dCMP and dUMP, are shown as sticks. C- and N-termini of the protein chain are marked.

Figure 3 Differences in the active site arrangements in mTS-N4-OH-dCMP (green) against mTS-dUMP (cyan). Shown are N4-OH-dCMP, dUMP, several amino acids and a few ordered water molecules.
Figure 3

Differences in the active site arrangements in mTS-N4-OH-dCMP (green) against mTS-dUMP (cyan). Shown are N4-OH-dCMP, dUMP, several amino acids and a few ordered water molecules.

Structures B and C showed the enzyme to be involved in a ternary complex with N4-OH-dCMP and dihydrofolate (DHF). These two structures are virtually identical; therefore, only structure C, solved with better resolution (1.17 Å), will be discussed. The electron density map in mTS-N4-OH-dCMP-DHF is very well defined and continuous throughout the protein chains and ligand molecules, except for the glutamate portion of DHF with the electron density less clear and temperature B factors relatively high, the latter suggesting that the glutamate may (partially) occupy at least two conformations that have been consequently modeled in this work. The model shows the protein in the active conformation. Unlike with the mTS-N4-OH-dCMP structure, although, the active site in the mTS-N4-OH-dCMP-DHF structure is closed, the catalytic Cys 189 being covalently bound to the C(6) atom of N4-OH-dCMP, reflected by the continuous electron density and distance of 1.87 Å between the C(6) and Cys 189 sulfur. Similar to the ligand molecules in the mTS-dUMP [9] and mTS-N4-OH-dCMP binary complexes, as well as dUMP molecule in the mTS-dUMP-ZD1694 ternary complex (PDB ID: 4EB4) (A. Dowierciał et al., unpublished), the molecule of N4-OH-dCMP is anchored in the active site by several H-bonds to its phosphate moiety from a group of four arginines and single serine (not shown). In accordance with our previous results [4] and molecular dynamics simulations results (A. Jarmuła et al., unpublished), the inhibitor molecule adopts the anti rotameric form in both the mTS-N4-OH-dCMP-DHF and mTS-N4-OH-dCMP structures.

The cofactor molecule is bound in the active site with the help of a single water-bridged H-bond between its glutamate α-carboxylic group and the side chain of Lys 71 (not shown). This H-bond confirms the postulated role of Lys 71 in the binding of the cofactor molecule [15]. Surprisingly, the electron density in the mTS-N4-OH-dCMP-DHF structure indicates the presence of noncovalently bound DHF, instead of expected mTHF (present in the crystallization buffer), suggesting the inhibition to be a consequence of an abortive enzyme-catalyzed reaction, involving a transfer of the one-carbon group to a hitherto unknown site and oxidation of tetrahydrofolate (THF) to DHF. Moreover, both C(5) and C(6) inhibitor atoms showed sp3 hybridization (cf. [3]), suggesting C(5) reduction and no indication of proton release from C(5) was apparent. Analysis of the electron density map showed no indication of a possible location of the one-carbon group released from the mTHF cofactor molecule.

The superimposition of the structures of mTS-N4-OH-dCMP and mTS-N4-OH-dCMP-DHF is shown in Figure 4. The Cα RMSD between both structures is 0.603 Å for subunits A and 0.449 Å for subunits B of the dimeric mTS protein. The most pronounced differences concern the C-terminus (residues Met 305, Ala 306 and Val 307) that is largely shifted in the ternary compared to binary complex, thus contributing to the active site closing. The other differences concern regions adjacent to the active site cleft. In the ternary compared to binary complex, some neighboring residues extend to the inside of the cleft, causing its narrowing (e.g., residues Leu 186, Phe 111, Leu 115) and/or stabilizing the hydrophobic para-aminobenzoic acid ring of the DHF molecule (residues Leu 215, Phe 219, Ile 102). Further stabilization of the position of the DHF molecule is provided with water-mediated hydrogen bonding connecting the N1, N2 and N3 atoms of the cofactor pterine ring with protein residues of Asp 212, Ala 306 and Arg 44 (Figure 5).

Figure 4 Superimposition of subunits A (the corresponding subunits in both structures) in the mTS-N4-OH-dCMP (pink) and mTS-N4-OH-dCMP-DHF (blue) complexes. Ligands, N4-OH-dCMP and DHF, are shown as sticks. C- and N-termini of the protein chain are marked.
Figure 4

Superimposition of subunits A (the corresponding subunits in both structures) in the mTS-N4-OH-dCMP (pink) and mTS-N4-OH-dCMP-DHF (blue) complexes. Ligands, N4-OH-dCMP and DHF, are shown as sticks. C- and N-termini of the protein chain are marked.

Figure 5 The active site of the mTS-N4-OH-dCMP-DHF complex (residues colored in green). Selected residues from the superimposed mTS-N4-OH-dCMP complex and the N4-OH-dCMP molecule are colored yellow. Selected water molecules are shown as red balls.
Figure 5

The active site of the mTS-N4-OH-dCMP-DHF complex (residues colored in green). Selected residues from the superimposed mTS-N4-OH-dCMP complex and the N4-OH-dCMP molecule are colored yellow. Selected water molecules are shown as red balls.

Figure 6 shows an important H-bonding network involving four water molecules (from which only one, W 405, does not have an equivalent in the binary complex), conservative residues of Cys 189, Tyr 129, Glu 81 and Asn 220, and the ligands, N4-OH-dCMP and DHF. Interestingly, the postulated molecule of water 405 exhibits only half-occupation, despite its apparently central role in mediating the aforementioned H-bonding network, wherein W 405 serves as a H-bond donor to DHF N5 and N4-OH-dCMP N4, as well as H-bond acceptor from DHF N10 and the amine group of Asn 220. The N4-OH-dCMP N4-W 405-Asn 220 H-bond shows a better geometrical fit and seems to be preferred over a direct (non-water-mediated) H-bond between N4-OH-dCMP N4 and Asn 220, present in the mTS-N4-OH-dCMP structure. It is worth noting that molecule W 405, located nearby the N5 and N10 atoms of the cofactor, appears unique among the hitherto investigated binary and ternary complexes of thymidylate synthases from different sources. Similarly located water molecules have been found only in three structures from the Protein Data Bank {EcTS-dUMP-THF, PDB ID: 1KZI [16], EcTS-5-nitro-dUMP-THF, PDB ID: 3BHL (unpublished), and LcTS-dTMP-DHF, PDB ID: 1LCB [17]}, none of which was found directly hydrogen bonded to the cofactor. The O4 atom in the N4-OH group of N4-OH-dCMP is stabilized by two hydrogen bonds (forming part of the H-bonding network shown in Figure 6), serving as (i) H-bond donor for one of the water molecules coordinated by the side chain of Gly 81 and N10 of DHF and (ii) H-bond acceptor for water W1, coordinated also by the catalytic Cys 189 and hydroxylic group of Tyr 129. Similar to the binary complex with inhibitor, the N3-H group of N4-OH-dCMP in the ternary complex preserves the hydrogen bond to Asn 220. Together, the two structures with the inhibitor, mTS-N4-OH-dCMP and mTS-N4-OH-dCMP-DHF, preserve, although in slightly different ways, all “conservative” hydrogen bonds formed between the protein and substrate (dUMP) [9]. The latter may explain the distinct preference (exerted in both the binary and ternary complexes) of the mTS protein for binding of the rarely populated anti rotameric form of the N4-OH-dCMP molecule.

Figure 6 Hydrogen bonding network in mTS-N4-OH-dCMP-DHF connecting the ligands (N4-OH-dCMP and DHF) with nearby amino acids (Asn 220, Glu 81 and Tyr 129) through ordered water molecules (including W 405 and W 1).
Figure 6

Hydrogen bonding network in mTS-N4-OH-dCMP-DHF connecting the ligands (N4-OH-dCMP and DHF) with nearby amino acids (Asn 220, Glu 81 and Tyr 129) through ordered water molecules (including W 405 and W 1).


Corresponding author: Wojciech Rode, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland, Fax: +48-22-822-5342

Supported by the National Science Centre Grant No. 2011/01/B/NZ6/01781 and the Ministry of Science and Higher Education (Grant No. N301 3948 33).

References

1. Rode W, Leś A. Molecular mechanism of thymidylate synthase-catalyzed reaction and interaction of the enzyme with 2- and/or 4-substituted analogues of dUMP and 5-fluoro-dUMP. Acta Biochim Pol 1996;43:133–42.10.18388/abp.1996_4524Search in Google Scholar

2. Lorenson MY, Maley GF, Maley F. The purification and properties of thymidylate synthetase from chick embryo extracts. J Biol Chem 1967;242:3332–44.10.1016/S0021-9258(18)95914-4Search in Google Scholar

3. Goldstein S, Pogolotti AL, Garvey EP Jr, Santi DV. Interaction of N4-hydroxy-2-deoxycytidylic acid with thymidylate synthetase. J Med Chem 1984;27:1259–62.10.1021/jm00376a004Search in Google Scholar PubMed

4. Rode W, Zieliński Z, Dzik JM, Kulikowski T, Bretner M, Kierdaszuk B, et al. Mechanism of inhibition of mammalian tumor and other thymidylate synthases by N4-hydroxy-dCMP, N4-hydroxy-5-fluoro-dCMP, and related analogues. Biochemistry 1990;29:10835–42.10.1021/bi00500a017Search in Google Scholar PubMed

5. Rode W, Dąbrowska M, Zieliński Z, Golos B, Wranicz M, Felczak K, et al. Trichinella spiralis and Trichinella pseudospiralis: developmental patterns of enzymes involved in thymidylate biosynthesis and pyrimidine salvage. Parasitology 2000;120:593–600.10.1017/S0031182099005880Search in Google Scholar

6. Felczak K, Miazga A, Poznański J, Bretner M, Kulikowski T, Dzik JM, et al. 5-Substituted N4-hydroxy-2′-deoxycytidines and their 5′-monophosphates: synthesis, conformation, interaction with tumor thymidylate synthase, and in vitro antitumor activity. J Med Chem 2000;43:4647–56.10.1021/jm000975uSearch in Google Scholar PubMed

7. Kierdaszuk B, Shugar D. Structure of the planar complex of N4-methoxycytosine with adenine, and its relevance to the mechanism of hydroxylamine mutagenesis. Biophys Chem 1983;17:285–95.10.1016/0301-4622(83)80013-1Search in Google Scholar PubMed

8. Kierdaszuk B, Stolarski R, Shugar D. Hydroxylamine, mutagenesis: observation of inverted Watson-Crick base pairing between N4-methoxyadenosine and adenine with the aid of natural-abundance high-resolution 15N NMR spectroscopy. Eur J Biochem 1983;30:559–64.10.1111/j.1432-1033.1983.tb07186.xSearch in Google Scholar PubMed

9. Dowierciał A, Jarmuła A, Rypniewski W, Sokolowska M, Fraczyk T, Ciesla J, et al. Crystal structures of substrate- and sulfate-bound mouse thymidylate synthase. Pteridines 2009;20(Special Issue):163–7.10.2210/pdb3ihi/pdbSearch in Google Scholar

10. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol Macromol Crystallogr 1997;276:307–26.10.1016/S0076-6879(97)76066-XSearch in Google Scholar PubMed

11. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Cryst 1994;D50:760–3.10.1107/S0907444994003112Search in Google Scholar PubMed

12. Finer-Moore JS, Santi DV, Stroud RM. Lessons and conclusions from dissecting the mechanism of a bi-substrate enzyme: thymidylate synthase mutagenesis, function and structure. Biochemistry 2003;42:248–56.10.1021/bi020599aSearch in Google Scholar PubMed

13. Liu L, Santi DV. Exclusion of 2′-deoxycytidine-5′-monophosphate by asparagine 229 of thymidylate synthase. Biochemistry 1993;32:9263–7.10.1021/bi00087a001Search in Google Scholar PubMed

14. Finer-Moore JS, Liu L, Schafmeister CE, Birdsall DL, Mau T, Santi DV, et al. Partitioning roles of side chains in affinity, orientation, and catalysis with structures for mutant complexes: asparagine-229 in thymidylate synthase. Biochemistry 1996;35:5125–36.10.1021/bi952751xSearch in Google Scholar PubMed

15. Arvizu-Flores AA, Sugich-Miranda R, Arreola R, Garcia-Orozco KD, Velazquez-Contreras EF, Montfort WR, et al. Role of an invariant lysine residue in folate binding on Escherichia coli thymidylate synthase: calorimetric and crystallographic analysis of the K48Q mutant. Int J Biochem Cell Biol 2008;40: 2206–17.10.1016/j.biocel.2008.02.025Search in Google Scholar PubMed PubMed Central

16. Fritz TA, Liu L, Finer-Moore JS, Stroud RM. Tryptophan 80 and leucine 143 are critical for the hydride transfer step of thymidylate synthase by controlling active site access. Biochemistry 2002;41:7021–9.10.1021/bi012108cSearch in Google Scholar PubMed

17. Finer-Moore JS, Fauman EB, Foster PG, Perry KM, Santi DV, Stroud RM. Refined structures of substrate-bound and phosphate-bound thymidylate synthase from Lactobacillus casei. J Mol Biol 1993;232:1101–16.10.1006/jmbi.1993.1463Search in Google Scholar PubMed

Received: 2013-2-22
Accepted: 2013-3-28
Published Online: 2013-05-03
Published in Print: 2013-06-01

©2013 by Walter de Gruyter Berlin Boston

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. New developments in the publication of Pteridines
  5. Chemistry
  6. First synthesis of asperopterin A, an isoxanthopterin glycoside from Aspergillus oryzae
  7. Tetrahydrobiopterin
  8. Three classes of tetrahydrobiopterin-dependent enzymes
  9. Tetrahydrobiopterin attenuates ischemia-reperfusion injury following organ transplantation by targeting the nitric oxide synthase: investigations in an animal model
  10. Inflammatory diseases
  11. Folates and antifolates in rheumatoid arthritis
  12. Immune activation and inflammation increase the plasma phenylalanine-to-tyrosine ratio
  13. Tryptophan degradation and neopterin levels by aging
  14. Spot analyses of serum neopterin, tryptophan and kynurenine levels in a random group of blood donor population
  15. Endothelial dysfunction, cardiovascular diseases
  16. Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation
  17. Immune activation and inflammation in patients with cardiovascular disease are associated with elevated phenylalanine-to-tyrosine ratios
  18. Malignant diseases treatment
  19. Thymidylate synthase inhibitors for thoracic tumors
  20. Polymorphisms correlated with the clinical outcome of locally advanced or metastatic colorectal cancer patients treated with ALIRI vs. FOLFIRI
  21. Folate homeostasis of cancer cells affects sensitivity to not only antifolates but also other non-folate drugs: effect of MRP expression
  22. Enzymology folates
  23. Crystal structures of thymidylate synthase from nematodes, Trichinella spiralis and Caenorhabditis elegans, as a potential template for species-specific drug design
  24. Crystal structures of complexes of mouse thymidylate synthase crystallized with N4-OH-dCMP alone or in the presence of N5,10-methylenetetrahydrofolate
  25. Enzymology pterins
  26. First insights into structure-function relationships of alkylglycerol monooxygenase
  27. Fatty aldehyde dehydrogenase, the enzyme downstream of tetrahydrobiopterin-dependent alkylglycerol monooxygenase
  28. Expression of full-length human alkylglycerol monooxygenase and fragments in Escherichia coli
  29. Enzyme occurrence and function in model organisms
  30. The diverse biological functions of glutathione S-transferase omega in Drosophila
  31. Uncommon and parallel developmental patterns of thymidylate synthase expression and localization in Trichinella spiralis and Caenorhabditis elegans
Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/pterid-2013-0010/html
Scroll to top button